Lilian Thibault

Founder @Awake

📍 Paris, Ile-de-France, France🔄 Updated September 2026💼 16 investments📅 12 years investing🗓 Last invested Jun 2025
Operator-angel🌍 France
16
Total investments
9
Early stage
3
Mid stage
3
Late stage
12y
Years active

Portfolio

15 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jun 2025
ArcaScience is setting the new standard for Benefit–Risk Assessment, leveraging AI to turn clinical uncertainty into up to +5% approval success. Our AI-Benefit-Risk Solution is the first to be fully aligned with CIOMS and ICH guidelines, featuring: > Regulatory-ready: BRA exports are compliant with CIOMS/FDA/EMA, ready for submission to regulatory agencies > Full expert control: every AI-generated item can be reviewed, edited, and validated by the expert > Cross-functional collaboration: pharmacovigilance, clinical, regulatory, and medical affairs teams work on a single shared platform across the entire drug lifecycle > AI-powered synthesis: automated identification, extraction, and structuring of clinical and safety data > 100% sourced, no hallucination: full traceability on every data point The Impact: We reduce BRA timelines from 3–8 months to just 2–3 days, deliver +5% market access, and provide best-in-class candidate optimization both during and after clinical trials.
Investor
Jan 2025
DrugOptimal propose un logiciel, extension du pharmacien, déployable en service auprès des soignants afin déviter les incompatibilités physico-chimiques médicamenteuses (IPC) en détectant les risques sur lordonnance et en proposant des solutions dadministration pour les éviter. Base de données de 105 000 couples, validée, et développée à partir dune compilation de 22 000 articles scientifiques, un modèle de prédiction des IPC par IA (+4000 paramètres physico-chimiques par couple) et notre propre laboratoire de recherche en chimie analytique (plateforme haut débit dédiée permettant danalyser plus de 1000 échantillons par jour). Notre champ daction : - Médicaments injectables : support au choix des solvants, concentrations, débits, PSE, aide à la réduction des contacts indésirables entre médicaments dans les tubulures, proposition de rampes de perfusion - Médicaments oraux : écrasabilité/section des médicaments et alternatives galéniques, interactions médicaments-aliments, modalités de prise
Investor
2023
Location de smartphones pour les particuliers et les entreprises à partir de 19,90€/mois
Investor
2023
Iconic collectibles embodied by the greatest athletes, sports legends and clubs.
early stageSpectator Sports
Investor
Jul 2022
xpln.ai develops new solutions for measuring and optimizing advertising effectiveness, supported by artificial intelligence, 100% cookieless, adapted to the new era of digital marketing.
Investor
Feb 2022
Ziwig Biotech is a biotechnology company pioneering the analysis of salivary RNA and the application of artificial intelligence to biomolecular biology. At the crossroads of medicine, data science, and digital technology, Ziwig develops non-invasive tests and therapeutic biomarkers designed to transform the diagnosis and management of chronic diseases—particularly those affecting women. Its flagship innovation, Endotest®, is the first non-invasive and highly reliable saliva-based test for the diagnosis of endometriosis. This breakthrough innovation, multiple award-winner (Galien Prize, Tech For Future Award), exemplifies Ziwig’s ability to revolutionize women’s health through the convergence of biotechnology, artificial intelligence, and precision medicine. Ziwig operates at the heart of a rapidly evolving global health ecosystem, where universal access to diagnosis and prevention is a major challenge for equity and sustainability. Through its scientific and societal commitment, Ziwig contributes to building a more human, accessible, and universal precision medicine—serving patients, healthcare professionals, and the health systems of the future. 🌐 www.ziwig.com
Investor
Nov 2021
The Enterprise SaaS platform that unlocks the full potential of your marketing data assets to deliver significant incremental revenue in retail, retail media, and media. Give your marketing team a unique data avantage. By providing our clients with a flexible, open and scalable tech backbone, we customise the solution to their needs to leverage it across all teams including marketing, sales, CRM, data and analytics to enable real-time activation across all major platforms. mediarithmics was founded in 2013, and currently works with some of the most advanced clients across Europe including Channel 4, Fnac-Darty, Havas Media, TF1, Canal+, Mulliez Group and many more.
Board Member
Mar 2020
Fondée par la navigatrice et scientifique Raphaëla Le Gouvello, RespectOcean est une association qui regroupe des acteurs et entreprises engagés pour un développement économique durable en faveur de la protection et de la préservation de l'océan, des littoraux et de leurs écosystèmes. Les membres du réseau portent des innovations et solutions qui contribuent à la préservation de l'océan ou incarnent les efforts à mettre en place pour réduire les impacts des activités économiques. Fin 2022, après un peu plus de quatre années d’existence officielle, RespectOcean a fédéré plus de 90 membres. Présente sur le territoire national, l'association regroupe une grande diversité d’acteurs, ayant comme dénominateur commun leur volonté de réduire l’impact de leurs activités sur les écosystèmes marins et côtiers et/ou de contribuer à les maintenir en bonne santé. Les missions principales de l'association sont de contribuer à la promotion de ces solutions et innovations, de favoriser les synergies entre les projets et de contribuer à la montée en puissance de l'économie durable pour l'océan. Pour cela, différents actions sont menées et notamment un programme de webinaires qui a un double objectif : mieux faire connaitre les enjeux et les problématiques liées à la préservation de l'océan et l'atteinte de l'Objectif du développement durable 14 ; faire connaitre les solutions portées par les acteurs économiques pour répondre à ces enjeux. L'association a une ouverture sur l'internationale puisqu'elle est alliée en France avec l'accélérateur de startup américaine Sustainable Ocean Alliance. Dans ce cadre, l'association porte un concours de pitchs (Ocean pitch challenge) à destination des acteurs français.
Investor
2020
5-minute summaries brought to you every week by human experts. Every Sunday, get access to the best of tech joining a community of leaders, entrepreneurs, and experts in business and tech. Get inspired and save time with their curation. You can subscribe for free. Never miss an update. Paying subscribers to receive regular case studies where we feature the best takeaways focused on one domain (like writing). Join brilliant people in business and tech and become one Save time reading every week the top5 Editor’s pick of our best leaders, entrepreneurs, experts, and indie writers in business and tech. JOIN BRILLIANT PEOPLE IN BUSINESS AND TECH AND BECOME ONE : Be part of a community of people who share your interests. The Timestamp partners with the best indie writers in business and tech to help them grow their audience and revenues. In case you know some experts that you would love to see featured in The Timestamp, you can share this newsletter 🌈
Investor
2019
Shop-Makers met à disposition des e-commerçants des solutions techniques et marketing leur permettant doptimiser leurs revenus et de fidéliser leurs clients. Nous offrons également des services shopping à nos membres de manière à récompenser leurs achats en ligne.
Investor
2018
AskMe.watch is the first watch search engine on principle-based of tailoring content. Our role is to provide the best digital experience to help users to get exactly what they are looking for at the right moment, and allow them to discover and select their next great watch. We are a global technology company that enables brands to connect more shoppers and increase performance. We’ve built the AMW Marketing Platform: an open, efficient, transparent, and fair environment where brands can have access to live data on our users behaviours: who is looking for what, when and where? Its value to our clients lies in its access to specified statistics, directly in order to manage market survey or advertising campaign impact. Join us in creating open collaboration for greater opportunity.
Investor
2018
Treatwell et Wavy unissent leurs forces 🤝 Pour ne rien rater de nos actualités, suivez la page ➡️ @Treatwell
Investor
2015
Happydemics empowers ad players around the world to precisely assess and optimize the ROI of their media strategies. With a proven methodology backed by over 25.000 benchmarks, Happydemics simplifies measurement across all media. As the trusted partner for more than 100 media players and thousands of advertisers worldwide, the scale up provides actionable ad analytics in a privacy-first era, setting a new standard in advertising effectiveness.
Investor
2015
This french laboratory has started with development of Tucky, the 1st wearable thermometer for remote & continuous fever monitoring. It now provides to hospitals & homecare providers a complete solution to monitor remotly patient vital parameters, based on various connected medical devices and a web-based management platform. This innovative company has ISO 13485 certificate and medical CE marking. contact@e-takescare.com
Investor
2014
Humanoid publishes modern online media on French Market, driven by one ambition: to be leaders in their category. Our editorial requirements and our vision of the media business have allowed our brands Frandroid, Numerama and Madmoizelle to become the references on new technologies, digital society, web culture and feminism. Today, our media have more than 18 million page views (2022) with as many passionate readers who return daily to read quality free media. Since 2016, humanoid xp is a team that puts our know-how at the service of brands to answer the most ambitious communication problems. Our creative agency can count on multiple skills, from brand content to web development, design and social media strategy. Humanoid has two multimedia studios to enrich its service offer with videos, lives and photos.
Experience · 18 entries
All (18)
Investments (16)
Founder (2)
Board (1)
2025
Investor
Jun 2025
ArcaScience is setting the new standard for Benefit–Risk Assessment, leveraging AI to turn clinical uncertainty into up to +5% approval success. Our AI-Benefit-Risk Solution is the first to be fully aligned with CIOMS and ICH guidelines, featuring: > Regulatory-ready: BRA exports are compliant with CIOMS/FDA/EMA, ready for submission to regulatory agencies > Full expert control: every AI-generated item can be reviewed, edited, and validated by the expert > Cross-functional collaboration: pharmacovigilance, clinical, regulatory, and medical affairs teams work on a single shared platform across the entire drug lifecycle > AI-powered synthesis: automated identification, extraction, and structuring of clinical and safety data > 100% sourced, no hallucination: full traceability on every data point The Impact: We reduce BRA timelines from 3–8 months to just 2–3 days, deliver +5% market access, and provide best-in-class candidate optimization both during and after clinical trials.
Investor
Jan 2025
DrugOptimal propose un logiciel, extension du pharmacien, déployable en service auprès des soignants afin déviter les incompatibilités physico-chimiques médicamenteuses (IPC) en détectant les risques sur lordonnance et en proposant des solutions dadministration pour les éviter. Base de données de 105 000 couples, validée, et développée à partir dune compilation de 22 000 articles scientifiques, un modèle de prédiction des IPC par IA (+4000 paramètres physico-chimiques par couple) et notre propre laboratoire de recherche en chimie analytique (plateforme haut débit dédiée permettant danalyser plus de 1000 échantillons par jour). Notre champ daction : - Médicaments injectables : support au choix des solvants, concentrations, débits, PSE, aide à la réduction des contacts indésirables entre médicaments dans les tubulures, proposition de rampes de perfusion - Médicaments oraux : écrasabilité/section des médicaments et alternatives galéniques, interactions médicaments-aliments, modalités de prise
2023
Investor
2023
Location de smartphones pour les particuliers et les entreprises à partir de 19,90€/mois
Investor
2023
Iconic collectibles embodied by the greatest athletes, sports legends and clubs.
early stageSpectator Sports
2022
Investor
Jul 2022
xpln.ai develops new solutions for measuring and optimizing advertising effectiveness, supported by artificial intelligence, 100% cookieless, adapted to the new era of digital marketing.
Show all 18 entries ↓
Investment activity
2014–2025 · 16 investments
201412015220182201912020320211202222023220252
Recent (last 2 years)Earlier